Tengion is a leader in the field of regenerative medicine, developing new human tissues and organs derived from a patient’s own cells. Tengion’s patented technology has the potential to allow adults and children with organ failure to have functioning organs built from their own tissues. At the Dow Jones Venture Wire Health Care Innovations conference, PodTech’s Jennifer Jones talks with CEO Steven Nichtberger about how his company is planning to save lives through these scientific advances.
